[1]
|
L. Richstone, D. S. Scherer, V. R. Reuter, M. E. Snyder, F. Rabbinic, M. W. Kaftan and P. Russo, “Multifocal Renal Cortical Tumors: Frequency, Associated Clinic Pathological Features and Impact on Survival,” Journal of Urology, Vol. 171, No. 2, 2004, pp. 615-620.
|
[2]
|
E. Mikael, M. Konichezky, D. Engelstein and C. Servadio, “Incidental Small Renal Tumors Accompanying Clinically Overt Renal Cell Carcinoma,” Journal of Urology, Vol. 140, No. 1, 1988, pp. 22-24.
|
[3]
|
M. R. Licht, A. C. Novick, R. R. Tubbs, E. A. Klein, H. S. Levin and S. B. Streem, “Renal Oncocytoma: Clinical and Biological Correlates,” Journal of Urology, Vol. 140, No. 5, 1993, pp. 1380-1383.
|
[4]
|
R. E. Jimenez, J. N. Eble, V. E. Reuter, J. I. Epstein, A. L. Folpe, M. de Peralta-Venturina, P. Tamboli, I. D. Ansell, D. J. Grignon, R. H. Young and M. B. Amin, “Concurrent Angiomyolipoma and Renal Cell Neoplasia: A Study of 36 Cases,” Modern Pathology, Vol. 14, No. 3, 2001, pp. 157-163. doi:10.1038/modpathol.3880275
|
[5]
|
A. A. Petrolla and G. T. MacLennan, “Renal Cell Carcinoma and Other Concurrent Renal Neoplasms,” Journal of Urology, Vol. 178, No. 5, 2007, p. 2163.
doi:10.1016/j.juro.2007.08.069
|
[6]
|
S. Baltaci, D. Orhan, S. Soyupek, Y. Bedük, O. Tulunay and O. Gogüs, “Influence of Tumor Stage, Size, Grade, Vascular Involvement, Histological Cell Type and Histological Pattern on Multifocality of Renal Cell Carcinoma,” Journal of Urology, Vol. 164, No. 1, 2000, pp. 36-39.
doi:10.1016/S0022-5347(05)67443-5
|
[7]
|
S. Y. Sargin, O. Ekmekcioglu, E. Arpali, M. Altinel and B. Voyvoda, “Multifocality Incidence and Accompanying Clinicopathological Factors in Renal Cell Carcinoma,” Urology Internationalis, Vol. 82, No. 3, 2009, pp. 324-329.
doi:10.1159/000209366
|
[8]
|
J. C. Cheville, C. M. Lohse, H. Zincke, A. L. Weaver and M. L. Blute, “Comparisons of Outcome and Prognostic Features among Histologic Subtypes of Renal Cell Carcinoma,” American Journal of Surgical Pathology, Vol. 27, No. 5, 2003, pp. 612-624.
doi:10.1097/00000478-200305000-00005
|
[9]
|
R. R. Lonser, G. M. Glenn, M. Walther, E. Y. Chew, S. K. Libutti, W. M. Linehan and E. H. Oldfield, “Von HippelLindau Disease,” Lancet, Vol. 361, No. 9374, 2003, pp. 2059-2067. doi:10.1016/S0140-6736(03)13643-4
|
[10]
|
O. Raz, S. Mendlovic, D. Leibovici, A. J. Pantuck, J. Sandbank, A. Sella, A. Lindner and A. Zisman, “The Prevalence of Malignancy in satellite Renal Lesions and Its Surgical Implication during Nephron Sparing Surgery,” Journal of Urology, Vol. 178, No. 5, 2007, pp. 1892-1895. doi:10.1016/j.juro.2007.07.009
|
[11]
|
B. P. Butler, A. C. Novick, D. P. Miller, S. A. Campbell and M. R. Licht, “Management of Small Unilateral Renal Cell Carcinomas: Radical versus Nephron-Sparing Surgery,” Urology, Vol. 45, No. 1, 1995, pp. 34-40.
doi:10.1016/S0090-4295(95)96306-5
|
[12]
|
S. E. Lerner, C. A. Hawkins, M. L. Blute, A. Grabner, P. C. Wollan, J. T. Eickholt and H. Zincke, “Disease Outcome in Patients with Low Stage Renal Cell Carcinoma Treated with Nephron Sparing or Radical Surgery,” Journal of Urology, Vol. 155, No. 6, 1966, pp. 1868-1873.
doi:10.1016/S0022-5347(01)66032-4
|
[13]
|
E. Mukamel, M. konichezky, D. Engelstein and C. Servadio, “Incidental Small Renal Tumors Accompanying Clinically Overt Renal Cell Carcinoma,” Journal of Urology, Vol. 140, No. 1, 1988, pp. 22-24.
|